Federal Register Notice: FDA’s collection of information entitled “Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans,” has been approved by the Office of Management and Budget under the Paperwork Reduction Act of 1995. To view this notice, click here.
